{"title":"品管圈在提高门诊幽门螺杆菌患者服药依从性中的实施效果。","authors":"Huan Gu, Huadong Jiang","doi":"10.1007/s10238-025-01864-z","DOIUrl":null,"url":null,"abstract":"<p><p>To evaluate the implementation effects of problem-solving Quality Control Circle (QCC) activities on medication adherence among outpatient Helicobacter pylori patients. Pharmacists collected data scales, guidance sheets, registration forms, and scoring sheets from outpatient H. pylori patients from January to March 2024. Through brainstorming, factors affecting medication adherence were identified and a series of specific measures were formulated. Implementation was carried out from April to July 2024, and the therapeutic effects of patients before and after implementing the QCC process were evaluated. The total score of patient medication adherence improved from 7.9 to 9.2, with statistically significant results (P < 0.001). The medication compliance rate increased from 57.46% to 87.62%; the adverse reaction incidence decreased from 39 to 11%; the C14 breath test positive rate decreased from 67.2% to 30.65%. All the above results showed statistically significant differences (P < 0.001). Implementing QCC can standardize and improve medication adherence measures for H. pylori patients, which has practical significance for patient treatment outcomes, while also enhancing pharmacists' professional knowledge and skills.</p>","PeriodicalId":10337,"journal":{"name":"Clinical and Experimental Medicine","volume":"25 1","pages":"313"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405293/pdf/","citationCount":"0","resultStr":"{\"title\":\"Implementation effects of quality control circle in improving medication adherence of outpatient helicobacter pylori patients.\",\"authors\":\"Huan Gu, Huadong Jiang\",\"doi\":\"10.1007/s10238-025-01864-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To evaluate the implementation effects of problem-solving Quality Control Circle (QCC) activities on medication adherence among outpatient Helicobacter pylori patients. Pharmacists collected data scales, guidance sheets, registration forms, and scoring sheets from outpatient H. pylori patients from January to March 2024. Through brainstorming, factors affecting medication adherence were identified and a series of specific measures were formulated. Implementation was carried out from April to July 2024, and the therapeutic effects of patients before and after implementing the QCC process were evaluated. The total score of patient medication adherence improved from 7.9 to 9.2, with statistically significant results (P < 0.001). The medication compliance rate increased from 57.46% to 87.62%; the adverse reaction incidence decreased from 39 to 11%; the C14 breath test positive rate decreased from 67.2% to 30.65%. All the above results showed statistically significant differences (P < 0.001). Implementing QCC can standardize and improve medication adherence measures for H. pylori patients, which has practical significance for patient treatment outcomes, while also enhancing pharmacists' professional knowledge and skills.</p>\",\"PeriodicalId\":10337,\"journal\":{\"name\":\"Clinical and Experimental Medicine\",\"volume\":\"25 1\",\"pages\":\"313\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405293/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10238-025-01864-z\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10238-025-01864-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Implementation effects of quality control circle in improving medication adherence of outpatient helicobacter pylori patients.
To evaluate the implementation effects of problem-solving Quality Control Circle (QCC) activities on medication adherence among outpatient Helicobacter pylori patients. Pharmacists collected data scales, guidance sheets, registration forms, and scoring sheets from outpatient H. pylori patients from January to March 2024. Through brainstorming, factors affecting medication adherence were identified and a series of specific measures were formulated. Implementation was carried out from April to July 2024, and the therapeutic effects of patients before and after implementing the QCC process were evaluated. The total score of patient medication adherence improved from 7.9 to 9.2, with statistically significant results (P < 0.001). The medication compliance rate increased from 57.46% to 87.62%; the adverse reaction incidence decreased from 39 to 11%; the C14 breath test positive rate decreased from 67.2% to 30.65%. All the above results showed statistically significant differences (P < 0.001). Implementing QCC can standardize and improve medication adherence measures for H. pylori patients, which has practical significance for patient treatment outcomes, while also enhancing pharmacists' professional knowledge and skills.
期刊介绍:
Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology. The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies. Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance. Case reports will be accepted on an exceptional basis only, and their submission is discouraged. The major criteria for publication are clarity, scientific soundness, and advances in knowledge. In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.